The company announced the change, which will take effect in July, as part of its first-quarter earnings. The new name will be Bausch Health Companies, to reflect the company’s better-known and more respected subsidiary, the eye care company Bausch + Lomb, which it acquired in 2013. Valeant Pharmaceuticals International, the company whose enormous price increases on old drugs helped fuel public outrage over high drug costs, is changing its name, the company announced Tuesday. Valeant, Distancing Itself From Its Past, Will Change Its Name To Bausch Health “We are much more than a pharmaceutical company.” “We think this name captures who we really are becoming,” said Chief Executive Joseph Papa. Valeant announced that it will change its name to Bausch Health Companies. Pharma Company At Heart Of Price Gouging Outrage Shucks Old Name In Hopes For Fresh Start
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |